Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Prabhdeep Grewal

Pain Medicine San Antonio, TX Medical Doctor

NPI 1215156542 CMS profile 190899

11212 Sate Highway 151, Suite 150, San Antonio, TX 78251

Open in the dashboard

General payments

$48,283

179 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Prabhdeep Grewal of San Antonio, TX is reported in the CMS Open Payments database as having received $48,283 across 179 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $359 2
2022 General $1,312 5
2021 General $15,724 23
2020 General $26,683 57
2019 General $4,206 92

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Prabhdeep Grewal
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Prabhdeep Grewal were reported at $0. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Prabhdeep Grewal Pain Medicine median Middle half National median
2019 $4,206 $498 $126–$1,682 $163
2020 $26,683 $284 $80–$910 $114
2021 $15,724 $399 $112–$1,219 $132
2022 $1,312 $455 $137–$1,484 $149
2023 $359 $484 $128–$1,495 $160
2024 $0 $498 $131–$1,540 $164
2025 $0 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Medtronic USA, Inc. $25,357 63 payments
  2. Medtronic, Inc. $17,152 28 payments
  3. Nevro Corp. $1,749 43 payments
  4. SPR Therapeutics, Inc $1,628 2 payments
  5. Boston Scientific Corporation $1,473 23 payments
  6. Abbott Laboratories $676 15 payments
  7. Relievant Medsystems, Inc. $131 1 payment
  8. Stryker Corporation $65 1 payment
  9. DePuy Synthes Sales Inc. $52 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,690 17 payments
  2. Consulting Fee $12,098 18 payments
  3. Food and Beverage $5,839 118 payments
  4. Travel and Lodging $3,581 23 payments
  5. Education $76 3 payments
Products named General payments · program years 2019–2023
  1. INTELLIS Spinal Cord Neurostimulation $17,786 47 payments
  2. INTELLIS Spinal Cord Neurostimulation $7,699 12 payments
  3. SYNCHROMED $3,600 1 payment
  4. RESTORE Spinal Cord Neurostimulation $1,980 1 payment
  5. Senza Spinal Cord Stimulation System $1,749 43 payments
  6. SPRINT PNS System $1,628 2 payments
  7. RESTORE Spinal Cord Neurostimulation $1,400 2 payments
  8. Inflate FX $1,320 1 payment
  9. SPECTRA WAVEWRITER $1,159 10 payments
  10. SPECIFY SURESCAN MRI 5-6-5 $800 1 payment
  11. Other $3,592 49 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

179 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record